Why is Takeda stock so low?
A few days ago, the share price reached its all-time-low at $13.8: the downward movement was fueled by an unexpected suspension of its Phase-2 study of one of its experimental drugs (namely TAK-994), due to a safety issue.
Does Takeda make generic drugs?
Teva and Takeda's Japanese venture will offload most of its generics portfolio and a manufacturing site to Nichi-Iko Pharmaceutical as the partners "shift focus" to a smaller core of specialty drugs and targeted generics, Teva said Thursday.
What diseases does Takeda treat?
Areas of Focus
- Takeda aspires to transform the treatment of rare diseases in immunology, hematology, metabolic and lysosomal storage disorders. ...
- Our neuroscience therapeutic area is driven by the immense unmet need of patients with diseases of the central nervous system.